Literature DB >> 21635752

Two-tier charging in Maputo Central Hospital: costs, revenues and effects on equity of access to hospital services.

Barbara McPake1, Charles Hongoro, Giuliano Russo.   

Abstract

BACKGROUND: Special services within public hospitals are becoming increasingly common in low and middle income countries with the stated objective of providing higher comfort services to affluent customers and generating resources for under funded hospitals. In the present study expenditures, outputs and costs are analysed for the Maputo Central Hospital and its Special Clinic with the objective of identifying net resource flows between a system operating two-tier charging, and, ultimately, understanding whether public hospitals can somehow benefit from running Special Clinic operations.
METHODS: A combination of step-down and bottom-up costing strategies were used to calculate recurrent as well as capital expenses, apportion them to identified cost centres and link costs to selected output measures.
RESULTS: The results show that cost differences between main hospital and clinic are marked and significant, with the Special Clinic's cost per patient and cost per outpatient visit respectively over four times and over thirteen times their equivalent in the main hospital. DISCUSSION: While the main hospital cost structure appeared in line with those from similar studies, salary expenditures were found to drive costs in the Special Clinic (73% of total), where capital and drug costs were surprisingly low (2 and 4% respectively). We attributed low capital and drug costs to underestimation by our study owing to difficulties in attributing the use of shared resources and to the Special Clinic's outsourcing policy. The large staff expenditure would be explained by higher physician time commitment, economic rents and subsidies to hospital staff. On the whole it was observed that: (a) the flow of capital and human resources was not fully captured by the financial systems in place and stayed largely unaccounted for; (b) because of the little consideration given to capital costs, the main hospital is more likely to be subsidising its Special Clinic operations, rather than the other way around.
CONCLUSION: We conclude that the observed lack of transparency may create scope for an inequitable cross subsidy of private customers by public resources.

Entities:  

Mesh:

Year:  2011        PMID: 21635752      PMCID: PMC3127984          DOI: 10.1186/1472-6963-11-143

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  7 in total

1.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Cost and unit cost calculations using step-down accounting.

Authors:  Lesong Conteh; Damian Walker
Journal:  Health Policy Plan       Date:  2004-03       Impact factor: 3.344

3.  Two-tier charging strategies in public hospitals: implications for intra-hospital resource allocation and equity of access to hospital services.

Authors:  Barbara McPake; Kara Hanson; Christopher Adam
Journal:  J Health Econ       Date:  2006-12-04       Impact factor: 3.883

4.  Prospects for reform of hospital fees in sub-Saharan Africa: a case study of Niamey National Hospital in Niger.

Authors:  M Weaver; H Wong; A S Sako; R Simon; F Lee
Journal:  Soc Sci Med       Date:  1994-02       Impact factor: 4.634

5.  The cost of the district hospital: a case study in Malawi.

Authors:  A J Mills; J Kapalamula; S Chisimbi
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

6.  Private medical services in acute-care hospitals in Israel.

Authors:  A Shirom
Journal:  Int J Health Plann Manage       Date:  2001 Oct-Dec

7.  Dual practice in the health sector: review of the evidence.

Authors:  Paulo Ferrinho; Wim Van Lerberghe; Inês Fronteira; Fátima Hipólito; André Biscaia
Journal:  Hum Resour Health       Date:  2004-10-27
  7 in total
  7 in total

1.  Growth and welfare in mixed health system financing with physician dual practice in a developing economy: a case of Indonesia.

Authors:  Barış Alpaslan; King Yoong Lim; Yan Song
Journal:  Int J Health Econ Manag       Date:  2020-11-07

2.  Negotiating markets for health: an exploration of physicians' engagement in dual practice in three African capital cities.

Authors:  Giuliano Russo; Barbara McPake; Inês Fronteira; Paulo Ferrinho
Journal:  Health Policy Plan       Date:  2013-09-26       Impact factor: 3.344

3.  Assessment of the societal cost of Taenia solium in Angónia district, Mozambique.

Authors:  Chiara Trevisan; Brecht Devleesschauwer; Nicolas Praet; Alberto Pondja; Yunus Amade Assane; Pierre Dorny; Stig Milan Thamsborg; Pascal Magnussen; Maria Vang Johansen
Journal:  BMC Infect Dis       Date:  2018-03-13       Impact factor: 3.090

Review 4.  Contracting out to improve the use of clinical health services and health outcomes in low- and middle-income countries.

Authors:  Willem A Odendaal; Kim Ward; Jesse Uneke; Henry Uro-Chukwu; Dereck Chitama; Yusentha Balakrishna; Tamara Kredo
Journal:  Cochrane Database Syst Rev       Date:  2018-04-03

5.  Caesarean section rates in Mozambique.

Authors:  Qian Long; Taina Kempas; Tavares Madede; Reija Klemetti; Elina Hemminki
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-12       Impact factor: 3.007

6.  The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.

Authors:  Filip Meheus; Abuzaid A Abuzaid; Rob Baltussen; Brima M Younis; Manica Balasegaram; Eltahir A G Khalil; Marleen Boelaert; Ahmed M Musa
Journal:  Am J Trop Med Hyg       Date:  2013-11-04       Impact factor: 2.345

7.  Why do some physicians in Portuguese-speaking African countries work exclusively for the private sector? Findings from a mixed-methods study.

Authors:  Giuliano Russo; Bruno de Sousa; Mohsin Sidat; Paulo Ferrinho; Gilles Dussault
Journal:  Hum Resour Health       Date:  2014-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.